Brendan J Kelly, MD, MS
Assistant Professor of Medicine (Infectious Diseases) at the Hospital of the University of Pennsylvania
Attending Physician, Penn Presbyterian Medical Center
Attending Physician, Hospital of the University of Pennsylvania
Director Fecal Microbiota Transplantation Program, Hospital of the University of Pennsylvania
Attending Physician, Good Shepherd Penn Partners
Senior Scholar, Center for Clinical Epidemiology and Biostatistics
Director, Antimicrobial Resistance and Healthcare Epidemiology Study collaborative (ARES) Scientific Laboratory, University of Pennsylvania
Department: Medicine
Contact information
731 Blockley Hall
Philadelphia, PA 19104
Philadelphia, PA 19104
Publications
Education:
AB (History and Science)
Harvard College, Harvard University, 2002.
MD
College of Physicians and Surgeons, Columbia University, 2007.
MSCE (Genetic Epidemiology)
Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, 2013.
Permanent linkAB (History and Science)
Harvard College, Harvard University, 2002.
MD
College of Physicians and Surgeons, Columbia University, 2007.
MSCE (Genetic Epidemiology)
Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, 2013.
Description of Clinical Expertise
respiratory tract infection; Clostridium difficile infection; HIVDescription of Research Expertise
microbial ecology; next-generation sequencing; respiratory tract microbiome; ventilator-associated infection; antimicrobial resistance; Clostridium difficile infectionSelected Publications
John F. Jachimiak & Brendan J. Kelly: Deciphering the microbiome in patients with C. difficile and inflammatory bowel disease: challenges to analysis. Digestive Disease Week (DDW) 2023, Chicago, IL May 2023.Matthew J. Ziegler, Selamawit Bekele, Sean Loughrey, Elizabeth Huang, Pam Tolomeo, Brendan J. Kelly : Bacterial community similarity between patient and healthcare environment increases during hospitalization. European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) 2023 (Copenhagen, Denmark) April 2023.
Matthew J. Ziegler, Selamawit Bekele, Sean Loughrey, Elizabeth Huang, Pam Tolomeo, Brendan J. Kelly : The effect of antibiotic exposures on colonisation resistance to bacteria resident in the healthcare environment. European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) 2023 (Copenhagen, Denmark) April 2023.
Redding LE, Habing GG, Tu V, Bittinger KL, O'Day J, Pancholi P, Wang SH, Alexander A, Kelly BJ, Weese JS, Stull JW.: Infrequent intrahousehold transmission of Clostridioides difficile between pet owners and their pets. Zoonoses Public Health Feb 2023.
Strelau KM, Feuerstein-Simon R, Naseer N, Lang M, Rix K, Murray EJ, Morris JS, Wiebe DJ, Nelson HCM, Collman RG, Rodino KG, Bushman FD, Kelly BJ, Cannuscio CC: Variations in COVID-19 impacts by social vulnerability in Philadelphia, June 2020-December 2022. medRxiv 2023(2023.01.13.23284488), January 2023.
Anderson TL, Nande A, Merenstein C, Raynor B, Oommen A, Kelly BJ, Levy MZ, Hill AL.: Quantifying individual-level heterogeneity in infectiousness and susceptibility through household studies. medRxiv Dec 2022.
Smith AB, Jenior ML, Keenan O, Hart JL, Specker J, Abbas A, Rangel PC, Di C, Green J, Bustin KA, Gaddy JA, Nicholson MR, Laut C, Kelly BJ, Matthews ML, Evans DR, Van Tyne D, Furth EE, Papin JA, Bushman FD, Erlichman J, Baldassano RN, Silverman MA, Dunny GM, Prentice BM, Skaar EP, Zackular JP.: Enterococci enhance Clostridioides difficile pathogenesis. Nature Nov 2022.
Marques AD, Sherrill-Mix S, Everett JK, Adhikari H, Reddy S, Ellis JC, Zeliff H, Greening SS, Cannuscio CC, Strelau KM, Collman RG, Kelly BJ, Rodino KG, Bushman FD, Gagne RB, Anis E.: Multiple Introductions of SARS-CoV-2 Alpha and Delta Variants into White-Tailed Deer in Pennsylvania. mBio 13: e0210122, Aug 2022.
Rodino KG, Peaper DR, Kelly BJ, Bushman F, Marques A, Adhikari H, Tu ZJ, Marrero Rolon R, Westblade LF, Green DA, Berry GJ, Wu F, Annavajhala MK, Uhlemann AC, Parikh BA, McMillen T, Jani K, Babady NE, Hahn AM, Koch RT, Grubaugh ND; Yale SARS-CoV-2 Genomic Surveillance Initiative, Rhoads DD.: Partial ORF1ab Gene Target Failure with Omicron BA.2.12.1. J Clin Microbiol 60: e0060022, Jun 2022.
Lenz OC, Marques AD, Kelly BJ, Rodino KG, Cole SD, Perera RAPM, Weiss SR, Bushman FD, Lennon EM.: SARS-CoV-2 Delta Variant (AY.3) in the Feces of a Domestic Cat. Viruses 14: 421, Feb 2022.